Trial Profile
Effects of Brain Beta Amyloid on Postoperative Cognition and 18F-AV-45-A14: Clinical Evaluation of Florbetapir F 18 (18F-AV-45)
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 22 Dec 2022
Price :
$35
*
At a glance
- Drugs Florbetapir F 18 (Primary)
- Indications Alzheimer's disease
- Focus Diagnostic use
- 16 Dec 2022 Planned End Date changed from 1 Jun 2022 to 1 Jun 2023.
- 16 Dec 2022 Planned primary completion date changed from 1 Jun 2022 to 1 Jun 2023.
- 11 May 2021 Planned End Date changed from 1 Jun 2020 to 1 Jun 2022.